SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001551152-22-000010
Filing Date
2022-04-29
Accepted
2022-04-29 07:45:08
Documents
15
Period of Report
2022-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abbv-20220429.htm   iXBRL 8-K 64694
2 EXHIBIT 99.1 abbv-20220331xexhibit991.htm EX-99.1 266561
7 abbvieimage1a53a.jpg GRAPHIC 15145
  Complete submission text file 0001551152-22-000010.txt   631637

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20220429.xsd EX-101.SCH 4517
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20220429_def.xml EX-101.DEF 21217
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abbv-20220429_lab.xml EX-101.LAB 43841
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20220429_pre.xml EX-101.PRE 21976
9 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20220429_htm.xml XML 30162
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 22870238
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences